Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan

doi:10.4239/wjd.v4.i6.358

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7491)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

490

WORD

340

HTML

3485

Figures (1-2)

639

Tables (1-2)

236

Sum=5190

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1112

Download

1189

Sum=2301

Dec 15, 2013 (publication date) through Feb 5, 2025

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Diabetes. Dec 15, 2013; 4(6): 358-364
Published online Dec 15, 2013. doi: 10.4239/wjd.v4.i6.358

Full Size Figure Download Figure

Figure 2 Mean body weight at pre- and post-Ramadan period. ^aP < 0.01. Vildagliptin group: Patients receiving vildagliptin ± metformin; Sulfonylurea group: Patients receiving sulfonylurea ± metformin.

Citation: Shete A, Shaikh A, Nayeem KJ, Rodrigues L, Ali MSS, Shah P, Khanna R, Majid S, Rasheed SA, Shaikh S, Rahman T. Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan. World J Diabetes 2013; 4(6): 358-364
URL: https://www.wjgnet.com/1948-9358/full/v4/i6/358.htm
DOI: https://dx.doi.org/10.4239/wjd.v4.i6.358